Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2022)

Atea Pharmaceuticals has reported Tax Provisions over the past 2 years, most recently at $123000.0 for Q4 2022.

  • Quarterly results put Tax Provisions at $123000.0 for Q4 2022, down 97.0% from a year ago — trailing twelve months through Dec 2022 was -$3.6 million (down 120.63% YoY), and the annual figure for FY2025 was -$6.2 million, down 766.16%.
  • Tax Provisions for Q4 2022 was $123000.0 at Atea Pharmaceuticals, up from -$3.8 million in the prior quarter.
  • Over the last five years, Tax Provisions for AVIR hit a ceiling of $7.2 million in Q2 2021 and a floor of -$3.8 million in Q3 2022.